Key terms
About PHIO
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PHIO news
Apr 11
7:33am ET
Phio Pharmaceuticals announces upcoming presentation on PH-762 at ASCGT
Apr 03
7:35am ET
Phio Pharmaceuticals says INTASYL platform to be focus of ‘Viewpoint’
Apr 03
2:01am ET
Phio Pharmaceuticals on the Brink: Nasdaq Delisting Looms Over Falling Stock Prices
Apr 02
7:39am ET
Phio Pharmaceuticals reports FY23 EPS ($5.20) vs ($10.10) last year
Mar 21
7:40am ET
Phio Pharmaceuticals presents data about INTASYL
Mar 13
2:02pm ET
Phio announces addition of three clinical trial sites for Phase 1b study
Mar 06
10:34am ET
Phio Pharmaceuticals announces patent grant by USPTO
Feb 06
6:20am ET
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Phio Pharmaceuticals (PHIO)
Feb 06
6:08am ET
Phio Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
Jan 31
8:10am ET
Phio Pharmaceuticals announces new preclinical data on INTASYL
No recent press releases are available for PHIO
PHIO Financials
Key terms
Ad Feedback
PHIO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PHIO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range